Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–64
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with type 2 diabetes (T2D) mellitus greater than equal to (≥) 180 days before screening.
Stable daily dose(s) ≥ 90 days prior to the day of screening of metformin ≥ 1500 milligrams (mg) or maximum tolerated or effective dose.
HbA1c of 7.0-10.5 percentage (%) \[53-91.3 millimoles per mole (mmol/mol)\] (both inclusive).
Uncontrolled and potentially unstable diabetic retinopathy or maculopathy. Verified by a fundus examination performed within 90 days before screening or in the period between screening and randomisation. Pharmacological pupil-dilation is a requirement unless using a digital fundus photography camera specified for nondilated examination.
You may not be if
Known or suspected hypersensitivity to study intervention(s) or related products.
Clareo Health | A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes
